MTOR and breast cancer: In addition, p‐S6K, the mTOR pathway effector related to cell proliferation decreased after MICAL1 overexpression and increased after MICAL1 depletion (Figure 3E), suggesting that the MICAL1 function in breast cancer cell proliferation was probably not mediated by mTOR/S6K signalling.